Glenmede Trust’s Chimerix, Inc. CMRX Stock Holding History

Glenmede Trust’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-6,992	Closed	-$17K	–	2318
2020 Q3	$17K	Hold	6,992	–	–	﹤0.01%	1680
2020 Q2	$21K	Hold	6,992	–	–	﹤0.01%	1583
2020 Q1	$14K	Hold	6,992	–	–	﹤0.01%	2271
2019 Q4	$14K	Hold	6,992	–	–	﹤0.01%	2271
2019 Q3	$16	Hold	6,992	–	–	﹤0.01%	2159
2019 Q2	$30	Hold	6,992	–	–	﹤0.01%	1909
2019 Q1	$14	Hold	6,992	–	–	﹤0.01%	2243
2018 Q4	$17	Buy	+6,992	New	+$23.4K	﹤0.01%	2064
2018 Q3	–	Sell	-6,992	Closed	-$33K	–	1872
2018 Q2	$33K	Hold	6,992	–	–	﹤0.01%	1580
2018 Q1	$32K	Hold	6,992	–	–	﹤0.01%	1801
2017 Q4	$32K	Hold	6,992	–	–	﹤0.01%	1801
2017 Q3	$36K	Hold	6,992	–	–	﹤0.01%	1767
2017 Q2	$44K	Hold	6,992	–	–	﹤0.01%	1653
2017 Q1	$44K	Hold	6,992	–	–	﹤0.01%	1653
2016 Q4	$32K	Hold	6,992	–	–	﹤0.01%	1754
2016 Q3	$38K	Hold	6,992	–	–	﹤0.01%	1711
2016 Q2	$27K	Hold	6,992	–	–	﹤0.01%	1797
2016 Q1	$35K	Hold	6,992	–	–	﹤0.01%	1638
2015 Q4	$62K	Hold	6,992	–	–	﹤0.01%	1500
2015 Q3	$267K	Buy	+6,992	New	+$345K	﹤0.01%	1110
2014 Q4	–	Sell	-4,460	Closed	-$123K	–	2625
2014 Q3	$123K	Buy	+4,460	New	+$108K	﹤0.01%	1366

Other funds holding CMRX

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Glenmede Trust's CMRX Position: Q4 2020 in Review

Glenmede Trust sold out of Chimerix, Inc. (CMRX) in Q4 2020, closing a stake of 6,992 shares — an estimated $17K sold.

Glenmede Trust first reported a position in CMRX in Q3 2014 and held it in 21 quarters. The position peaked at $267K in Q3 2015. 93 funds tracked by Wall St. Rank hold CMRX as of Q4 2020.

Glenmede Trust reported no remaining Chimerix, Inc. position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 6,992 Chimerix, Inc. shares in Q4 2020, an estimated $17K.
Glenmede Trust first reported a position in Chimerix, Inc. in Q3 2014 and held it in 21 quarters.
Glenmede Trust's Chimerix, Inc. position peaked at $267K in Q3 2015.
93 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.